uniprot	swissprot	drug_name	act_value	act_type	action_type	source_name	reference	smiles	ChEMBL_Id
P42338	PK3CB_HUMAN	copanlisib	8.431797981262207	IC50	INHIBITOR	SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/24170767	COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21	CHEMBL3218576
P21917	DRD4_HUMAN	brexpiprazole	8.200659451	Ki	AGONIST	SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/24947465	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2	CHEMBL2105760
P50406	5HT6R_HUMAN	brexpiprazole	7.236572006	Ki		SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/24947465	O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2	CHEMBL2105760
P51575	P2RX1_HUMAN	adenosine triphosphate	7.25	EC50	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O	CHEMBL14249
Q99571	P2RX4_HUMAN	adenosine triphosphate	6.3	EC50	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O	CHEMBL14249
Q9UKK3	PARP4_HUMAN	rucaparib	6.079999923706055	IC50	INHIBITOR	SCIENTIFIC LITERATURE	http://dx.doi.org/10.1021/acs.jmedchem.6b00990	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23	CHEMBL1173055
O95271	TNKS1_HUMAN	rucaparib	6.840000152587891	IC50	INHIBITOR	SCIENTIFIC LITERATURE	http://dx.doi.org/10.1021/acs.jmedchem.6b00990	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23	CHEMBL1173055
Q9H2K2	TNKS2_HUMAN	rucaparib	6.050000190734863	IC50	INHIBITOR	SCIENTIFIC LITERATURE	http://dx.doi.org/10.1021/acs.jmedchem.6b00990	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23	CHEMBL1173055
Q53GL7	PAR10_HUMAN	rucaparib	6.25	IC50	INHIBITOR	SCIENTIFIC LITERATURE	http://dx.doi.org/10.1021/acs.jmedchem.6b00990	CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23	CHEMBL1173055
Q9HC97	GPR35_HUMAN	lodoxamide	8.793173789978027	EC50	AGONIST	SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/24113750	OC(=O)C(=O)NC1=CC(=CC(NC(=O)C(O)=O)=C1Cl)C#N	CHEMBL1201175
P05981	HEPS_HUMAN	nafamostat	9.279999732971191	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N	CHEMBL273264
Q04756	HGFA_HUMAN	nafamostat	7.599999904632568	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N	CHEMBL273264
Q9BV23	ABHD6_HUMAN	orlistat	7.320000171661377	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	CHEMBL175247
P15328	FOLR1_HUMAN	pemetrexed	7.380000114440918	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	CHEMBL225072
P15328	FOLR1_HUMAN	raltitrexed	7.820000171661377	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071	CN(CC1=CC2=C(C=C1)N=C(C)NC2=O)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O	CHEMBL225071
P24158	PRTN3_HUMAN	sivelestat	6.46999979019165	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76688	CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=C(C=CC=C1)C(=O)NCC(O)=O	CHEMBL76688
Q07817	B2CL1_HUMAN	venetoclax	7.318758964538574	Ki	INHIBITOR	SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/23291630	CC1(C)CCC(CN2CCN(CC2)C2=CC(OC3=CC4=C(NC=C4)N=C3)=C(C=C2)C(=O)NS(=O)(=O)C2=CC(=C(NCC3CCOCC3)C=C2)[N+]([O-])=O)=C(C1)C1=CC=C(Cl)C=C1	CHEMBL3137309
Q92843	B2CL2_HUMAN	venetoclax	6.610834121704102	Ki	INHIBITOR	SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/23291630	CC1(C)CCC(CN2CCN(CC2)C2=CC(OC3=CC4=C(NC=C4)N=C3)=C(C=C2)C(=O)NS(=O)(=O)C2=CC(=C(NCC3CCOCC3)C=C2)[N+]([O-])=O)=C(C1)C1=CC=C(Cl)C=C1	CHEMBL3137309
P21917	DRD4_HUMAN	aripiprazole lauroxil	7.3565473556518555	Ki		DRUG LABEL	http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12	CHEMBL2219425
P21917	DRD4_HUMAN	flibanserin	8.397939682006836	Ki	ANTAGONIST	SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/12177684	FC(F)(F)C1=CC=CC(=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1	CHEMBL231068
Q6V1X1	DPP8_HUMAN	teneligliptin	6.585026741027832	IC50		SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/22959556	[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCSC1)N1CCN(CC1)C1=CC(C)=NN1C1=CC=CC=C1	CHEMBL2147777
Q86TI2	DPP9_HUMAN	teneligliptin	6.267606258392334	IC50		SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/22959556	[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCSC1)N1CCN(CC1)C1=CC(C)=NN1C1=CC=CC=C1	CHEMBL2147777
Q6V1X1	DPP8_HUMAN	anagliptin	7.1674909591674805	IC50		SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/22019046	CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N	CHEMBL1929387
Q86TI2	DPP9_HUMAN	anagliptin	7.221848964691162	IC50		SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/22019046	CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N	CHEMBL1929387
Q9BXA7	TSSK1_HUMAN	ceritinib	7.638272285461426	IC50		SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/23742252	CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1	CHEMBL2403108
Q9H3N8	HRH4_HUMAN	histamine	8.1	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90	NCCC1=CN=CN1	CHEMBL90
Q16853	AOC3_HUMAN	phenelzine	7.7	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089	NNCCC1=CC=CC=C1	CHEMBL1089
P36544	ACHA7_HUMAN	acetylcholine	5.1	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667	CC(=O)OCC[N+](C)(C)C	CHEMBL667
P51800	CLCKA_HUMAN	niflumic acid	5.0	EC50	ACTIVATOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2439	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1	CHEMBL63323
P21918	DRD5_HUMAN	apomorphine	7.8	Ki	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23	CHEMBL53
P47898	5HT5A_HUMAN	methysergide	7.0	Ki	ANTAGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134	[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO	CHEMBL1065
O00222	GRM8_HUMAN	dexfosfoserine	7.2	IC50	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1411	N[C@@H](COP(O)(O)=O)C(O)=O	CHEMBL284377
P50406	5HT6R_HUMAN	zotepine	8.3	Ki	ANTAGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103	CN(C)CCOC1=CC2=C(SC3=CC=C(Cl)C=C13)C=CC=C2	CHEMBL285802
P50406	5HT6R_HUMAN	thioridazine	7.2	Ki	ANTAGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100	[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C	CHEMBL479
P21918	DRD5_HUMAN	flupentixol	8.1	Ki	ANTAGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=948	OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1	CHEMBL42055
P21918	DRD5_HUMAN	cabergoline	7.7	Ki	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC	CHEMBL1201087
P28566	5HT1E_HUMAN	naratriptan	7.7	Ki	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=45	CNS(=O)(=O)CCC1=CC=C2NC=C(C3CCN(C)CC3)C2=C1	CHEMBL1278
Q14832	GRM3_HUMAN	glutamic acid	7.4	Ki	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1369	N[C@@H](CCC(O)=O)C(O)=O	CHEMBL76232
P21917	DRD4_HUMAN	cabergoline	7.3	Ki	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37	[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC	CHEMBL1201087
P50406	5HT6R_HUMAN	amoxapine	7.3	Ki	ANTAGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=201	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1	CHEMBL1113
Q14994	NR1I3_HUMAN	meclozine	7.16	IC50	ANTAGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2757	CC1=CC=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=C1	CHEMBL1623
O15554	KCNN4_HUMAN	nitrendipine	7.6	IC50	BLOCKER	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC	CHEMBL475534
O60840	CAC1F_HUMAN	nifedipine	6.0	IC50	GATING INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2514	COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC	CHEMBL193
O15554	KCNN4_HUMAN	riluzole	5.7	IC50	ACTIVATOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2326	NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2	CHEMBL744
Q8TD43	TRPM4_HUMAN	adenosine triphosphate	5.8	IC50	BLOCKER	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O	CHEMBL14249
P50406	5HT6R_HUMAN	ergotamine	8.6	Ki	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O	CHEMBL442
P28566	5HT1E_HUMAN	methylergometrine	7.2	Ki	ANTAGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=150	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO	CHEMBL1200843
P50406	5HT6R_HUMAN	metergoline	7.4	Ki	ANTAGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133	[H][C@]1(CNC(=O)OCC2=CC=CC=C2)CN(C)[C@]2([H])CC3=CN(C)C4=C3C(=CC=C4)[C@@]2([H])C1	CHEMBL19215
P21917	DRD4_HUMAN	terguride	8.1	Ki	ANTAGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56	[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC	CHEMBL73151
P50406	5HT6R_HUMAN	bromocriptine	7.5	Ki	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=35	[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C	CHEMBL493
P28566	5HT1E_HUMAN	eletriptan	7.2	Ki	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=40	CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2	CHEMBL1510
P14902	I23O1_HUMAN	menadione	6.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590	CC1=CC(=O)C2=CC=CC=C2C1=O	CHEMBL590
P37058	DHB3_HUMAN	hymecromone	6.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12208	CC1=CC(=O)OC2=C1C=CC(O)=C2	CHEMBL12208
P0DMS8	AA3R_HUMAN	theophylline	7.85	Ki	ANTAGONIST	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190	CN1C2=C(N=CN2)C(=O)N(C)C1=O	CHEMBL190
P50579	MAP2_HUMAN	nitroxoline	7.26	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1454910	OC1=C2N=CC=CC2=C(C=C1)[N+]([O-])=O	CHEMBL1454910
P14410	SUIS_HUMAN	miglitol	6.3	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1561	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	CHEMBL1561
P36544	ACHA7_HUMAN	varenicline	6.9	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396	[H][C@]12C[C@]([H])(CNC1)C1=C2C=C2N=CC=NC2=C1	CHEMBL1396
P21917	DRD4_HUMAN	pramipexole	9.31	Ki	AGONIST	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL301265	CCCN[C@H]1CCC2=C(C1)SC(N)=N2	CHEMBL301265
P0DMS8	AA3R_HUMAN	kainic acid	7.11	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040	CC(=C)[C@H]1CN[C@@H]([C@H]1CC(O)=O)C(O)=O	CHEMBL275040
P0DMS8	AA3R_HUMAN	baclofen	7.3	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL701	NCC(CC(O)=O)C1=CC=C(Cl)C=C1	CHEMBL701
P09960	LKHA4_HUMAN	captopril	7.15	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560	C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O	CHEMBL1560
Q9HCG7	GBA2_HUMAN	miglustat	6.64	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	CHEMBL1029
P14410	SUIS_HUMAN	miglustat	6.3	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	CHEMBL1029
P19099	C11B2_HUMAN	fadrozole	9.1	IC50	INHIBITOR	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9298	N#CC1=CC=C(C=C1)C1CCCC2=CN=CN12	CHEMBL9298
P19099	C11B2_HUMAN	metyrapone	7.38	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL934	CC(C)(C(=O)C1=CN=CC=C1)C1=CN=CC=C1	CHEMBL934
P24557	THAS_HUMAN	ozagrel	7.96	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11662	OC(=O)\C=C\C1=CC=C(CN2C=CN=C2)C=C1	CHEMBL11662
P78348	ASIC1_HUMAN	amiloride	5.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL945	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1	CHEMBL945
Q9UHC3	ASIC3_HUMAN	amiloride	5.36	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL945	NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1	CHEMBL945
P42330	AK1C3_HUMAN	naproxen	6.32	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL154	COC1=CC=C2C=C(C=CC2=C1)[C@H](C)C(O)=O	CHEMBL154
P16083	NQO2_HUMAN	melatonin	7.56	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL45	COC1=CC2=C(NC=C2CCNC(C)=O)C=C1	CHEMBL45
P34913	HYES_HUMAN	zileuton	6.23	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL93	CC(N(O)C(N)=O)C1=CC2=C(S1)C=CC=C2	CHEMBL93
Q99685	MGLL_HUMAN	thiram	6.01	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120563	CN(C)C(=S)SSC(=S)N(C)C	CHEMBL120563
P42330	AK1C3_HUMAN	mefenamic acid	6.52	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL686	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C	CHEMBL686
P52895	AK1C2_HUMAN	mefenamic acid	6.66	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL686	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C	CHEMBL686
Q04828	AK1C1_HUMAN	mefenamic acid	6.09	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL686	CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C	CHEMBL686
P42785	PCP_HUMAN	phencyclidine	7.04	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275528	C1CCN(CC1)C1(CCCCC1)C1=CC=CC=C1	CHEMBL275528
P19099	C11B2_HUMAN	etomidate	10.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23731	CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1	CHEMBL23731
P51575	P2RX1_HUMAN	pyridoxal phosphate	5.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL82202	CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O	CHEMBL82202
P10145	IL8_HUMAN	tolmetin	7.05	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1020	CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1	CHEMBL1020
P42330	AK1C3_HUMAN	tolfenamic acid	8.1	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121626	CC1=C(NC2=C(C=CC=C2)C(O)=O)C=CC=C1Cl	CHEMBL121626
P0DMS8	AA3R_HUMAN	protriptyline	8.96	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL668	CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2	CHEMBL668
P0DMS8	AA3R_HUMAN	atenolol	8.75	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24	CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1	CHEMBL24
P21917	DRD4_HUMAN	apomorphine	8.05	Ki	AGONIST	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53	[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23	CHEMBL53
P04278	SHBG_HUMAN	estrone	8.18	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1405	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3	CHEMBL1405
P14061	DHB1_HUMAN	estrone	8.52	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1405	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3	CHEMBL1405
P10636	TAU_HUMAN	tolonium	7.16	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1197206	CN(C)C1=CC2=[S+]C3=CC(N)=C(C)C=C3N=C2C=C1	CHEMBL1197206
P04278	SHBG_HUMAN	estradiol	8.83	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3	CHEMBL135
O95718	ERR2_HUMAN	estradiol	8.49	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3	CHEMBL135
P11474	ERR1_HUMAN	estradiol	8.44	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3	CHEMBL135
P04278	SHBG_HUMAN	nandrolone	6.3	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]	CHEMBL757
P0DMS8	AA3R_HUMAN	imipramine	8.36	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11	CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2	CHEMBL11
P05413	FABPH_HUMAN	linoleic acid	9.7	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267476	CCCCC\C=C/C\C=C/CCCCCCCC(O)=O	CHEMBL267476
P15090	FABP4_HUMAN	linoleic acid	6.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267476	CCCCC\C=C/C\C=C/CCCCCCCC(O)=O	CHEMBL267476
Q8TD43	TRPM4_HUMAN	flufenamic acid	5.55	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23588	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1	CHEMBL23588
Q01469	FABP5_HUMAN	oleic acid	6.61	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659	CCCCCCCC\C=C/CCCCCCCC(O)=O	CHEMBL8659
P07148	FABPL_HUMAN	oleic acid	6.7	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659	CCCCCCCC\C=C/CCCCCCCC(O)=O	CHEMBL8659
P15090	FABP4_HUMAN	oleic acid	6.73	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659	CCCCCCCC\C=C/CCCCCCCC(O)=O	CHEMBL8659
P36544	ACHA7_HUMAN	tropisetron	8.16	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2	CHEMBL56564
O95264	5HT3B_HUMAN	tropisetron	8.8	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2	CHEMBL56564
P0DMS8	AA3R_HUMAN	diazepam	7.92	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12	CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1	CHEMBL12
P0DMS8	AA3R_HUMAN	mepyramine	8.89	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511	COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1	CHEMBL511
P04278	SHBG_HUMAN	androstenedione	7.46	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274826	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL274826
P37058	DHB3_HUMAN	androstenedione	6.31	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274826	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL274826
P02753	RET4_HUMAN	retinol	6.74	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL986	C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C	CHEMBL986
P04278	SHBG_HUMAN	estriol	6.63	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482	[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3	CHEMBL193482
P04278	SHBG_HUMAN	testosterone	9.2	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL386630	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL386630
P04278	SHBG_HUMAN	prasterone	7.84	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90593	[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C	CHEMBL90593
P42785	PCP_HUMAN	caramiphen	7.59	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61946	CCN(CC)CCOC(=O)C1(CCCC1)C1=CC=CC=C1	CHEMBL61946
P16152	CBR1_HUMAN	triclosan	7.22	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL849	OC1=C(OC2=CC=C(Cl)C=C2Cl)C=CC(Cl)=C1	CHEMBL849
P04278	SHBG_HUMAN	androstanolone	9.74	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27769	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C	CHEMBL27769
P04278	SHBG_HUMAN	androstenediol	9.17	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440283	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C	CHEMBL440283
P24046	GBRR1_HUMAN	lindane	7.04	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15891	Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl	CHEMBL15891
Q14534	ERG1_HUMAN	terbinafine	7.52	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL822	CN(C\C=C\C#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1	CHEMBL822
Q86VL8	S47A2_HUMAN	ondansetron	6.8	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2	CHEMBL46
Q96FL8	S47A1_HUMAN	ondansetron	7.52	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2	CHEMBL46
O95264	5HT3B_HUMAN	ondansetron	8.3	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46	CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2	CHEMBL46
P42330	AK1C3_HUMAN	meclofenamic acid	6.27	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509	CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl	CHEMBL509
P10145	IL8_HUMAN	diclofenac	8.1	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1	CHEMBL139
P25024	CXCR1_HUMAN	diclofenac	7.92	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139	OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1	CHEMBL139
P04278	SHBG_HUMAN	ethinylestradiol	6.81	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL691	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3	CHEMBL691
O95264	5HT3B_HUMAN	palonosetron	9.74	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1720	[H][C@@]12CCCC3=CC=CC(C(=O)N(C1)[C@]1([H])CN4CCC1CC4)=C23	CHEMBL1720
P04278	SHBG_HUMAN	norethisterone	7.97	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1162	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]	CHEMBL1162
Q9NPH5	NOX4_HUMAN	quercetin	6.17	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50	OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1	CHEMBL50
Q16678	CP1B1_HUMAN	quercetin	7.11	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50	OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1	CHEMBL50
P18054	LOX12_HUMAN	quercetin	6.36	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50	OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1	CHEMBL50
P11309	PIM1_HUMAN	quercetin	7.6	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50	OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1	CHEMBL50
Q16678	CP1B1_HUMAN	hesperetin	6.29	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL399121	[H][C@]1(CC(=O)C2=C(O)C=C(O)C=C2O1)C1=CC(O)=C(OC)C=C1	CHEMBL399121
P18054	LOX12_HUMAN	masoprocol	6.96	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52	C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1	CHEMBL52
P16050	LOX15_HUMAN	masoprocol	6.96	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52	C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1	CHEMBL52
Q15722	LT4R1_HUMAN	masoprocol	7.07	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52	C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1	CHEMBL52
P04278	SHBG_HUMAN	methyltestosterone	8.43	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1395	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL1395
Q6V1X1	DPP8_HUMAN	vildagliptin	6.09	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL142703	OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N	CHEMBL142703
Q86TI2	DPP9_HUMAN	vildagliptin	7.17	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL142703	OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N	CHEMBL142703
P04278	SHBG_HUMAN	mesterolone	9.6	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL258918	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C[C@H](C)[C@]12C	CHEMBL258918
P04278	SHBG_HUMAN	mestanolone	8.81	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL261514	[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C	CHEMBL261514
Q9Y2Q3	GSTK1_HUMAN	glutathione	7.7	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1543	N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O	CHEMBL1543
Q15125	EBP_HUMAN	buflomedil	7.22	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL188921	COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1	CHEMBL188921
P28838	AMPL_HUMAN	ubenimex	9.22	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(O)=O	CHEMBL29292
P09960	LKHA4_HUMAN	ubenimex	6.3	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(O)=O	CHEMBL29292
P04278	SHBG_HUMAN	gestrinone	8.11	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1868702	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]	CHEMBL1868702
O75311	GLRA3_HUMAN	picrotin	5.22	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL478523	[H][C@@]12C[C@@]3(O)[C@@H]4[C@@H]([C@@H](OC4=O)[C@H]4OC(=O)[C@]1(O2)[C@@]34C)C(C)(C)O	CHEMBL478523
Q16850	CP51A_HUMAN	bifonazole	6.47	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL277535	C1=CN(C=N1)C(C1=CC=CC=C1)C1=CC=C(C=C1)C1=CC=CC=C1	CHEMBL277535
P04278	SHBG_HUMAN	desogestrel	6.6	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1533	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]	CHEMBL1533
O95264	5HT3B_HUMAN	granisetron	8.8	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289469	[H][C@]1(C[C@]2([H])CCC[C@]([H])(C1)N2C)NC(=O)C1=NN(C)C2=C1C=CC=C2	CHEMBL289469
P04278	SHBG_HUMAN	levonorgestrel	8.91	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1389	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]	CHEMBL1389
P04278	SHBG_HUMAN	ethisterone	8.78	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL241694	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL241694
P21917	DRD4_HUMAN	amoxapine	7.47	Ki	ANTAGONIST	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113	ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1	CHEMBL1113
P34972	CNR2_HUMAN	dronabinol	8.48	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465	[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21	CHEMBL465
P34972	CNR2_HUMAN	dronabinol	7.39	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465	[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21	CHEMBL465
P04278	SHBG_HUMAN	progesterone	6.94	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL103
Q6V1X1	DPP8_HUMAN	saxagliptin	6.89	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL385517	[H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)C12CC3CC(CC(O)(C3)C1)C2	CHEMBL385517
Q86TI2	DPP9_HUMAN	saxagliptin	7.15	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL385517	[H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)C12CC3CC(CC(O)(C3)C1)C2	CHEMBL385517
P21917	DRD4_HUMAN	rotigotine	7.26	Ki	AGONIST	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1303	CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1	CHEMBL1303
P34913	HYES_HUMAN	triclocarban	7.89	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1076347	ClC1=CC=C(NC(=O)NC2=CC(Cl)=C(Cl)C=C2)C=C1	CHEMBL1076347
P50406	5HT6R_HUMAN	chlorprothixene	8.52	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2	CHEMBL908
P21918	DRD5_HUMAN	chlorprothixene	8.05	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908	CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2	CHEMBL908
P04278	SHBG_HUMAN	pregnenolone succinate	7.15	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL253363	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)OC(=O)CCC(O)=O	CHEMBL253363
P08183	MDR1_HUMAN	chlorpromazine	6.22	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2	CHEMBL71
O60218	AK1BA_HUMAN	epalrestat	6.48	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56337	C\C(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1=CC=CC=C1	CHEMBL56337
O15244	S22A2_HUMAN	gabexate	6.05	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87563	CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1	CHEMBL87563
Q96FL8	S47A1_HUMAN	gabexate	6.3	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87563	CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1	CHEMBL87563
P47898	5HT5A_HUMAN	lysergide	8.05	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC	CHEMBL263881
P21917	DRD4_HUMAN	lysergide	7.25	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC	CHEMBL263881
P28566	5HT1E_HUMAN	lysergide	7.03	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC	CHEMBL263881
P54219	VMAT1_HUMAN	reserpine	7.45	Ki	INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4823	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2	CHEMBL772
P04278	SHBG_HUMAN	etonogestrel	8.23	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1531	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]	CHEMBL1531
P40763	STAT3_HUMAN	niclosamide	6.6	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448	OC1=C(C=C(Cl)C=C1)C(=O)NC1=C(Cl)C=C(C=C1)[N+]([O-])=O	CHEMBL1448
P0DMS8	AA3R_HUMAN	naloxone	8.8	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL80	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC=C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3O	CHEMBL80
P50406	5HT6R_HUMAN	loxapine	7.82	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2	CHEMBL831
P21917	DRD4_HUMAN	loxapine	8.31	Ki	ANTAGONIST	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2	CHEMBL831
Q99571	P2RX4_HUMAN	paroxetine	5.33	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490	[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1	CHEMBL490
P04278	SHBG_HUMAN	desoxycortone	7.38	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1498	[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL1498
Q02880	TOP2B_HUMAN	ciprofloxacin	7.52	EC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8	OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O	CHEMBL8
P21917	DRD4_HUMAN	zotepine	7.41	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285802	CN(C)CCOC1=CC2=C(SC3=CC=C(Cl)C=C13)C=CC=C2	CHEMBL285802
P42785	PCP_HUMAN	pentoxyverine	7.49	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL73234	CCN(CC)CCOCCOC(=O)C1(CCCC1)C1=CC=CC=C1	CHEMBL73234
Q9HC97	GPR35_HUMAN	dicoumarol	7.41	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1466	OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12	CHEMBL1466
Q96FL8	S47A1_HUMAN	famotidine	6.12	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL902	NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1	CHEMBL902
P04278	SHBG_HUMAN	danazol	8.2	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1479	[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3	CHEMBL1479
P19801	AOC1_HUMAN	pentamidine	6.54	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55	NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1	CHEMBL55
P04271	S100B_HUMAN	pentamidine	6.0	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55	NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1	CHEMBL55
Q96FL8	S47A1_HUMAN	pentamidine	6.39	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55	NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1	CHEMBL55
P42330	AK1C3_HUMAN	medroxyprogesterone	6.52	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C	CHEMBL717
P04278	SHBG_HUMAN	medroxyprogesterone	6.2	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717	[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C	CHEMBL717
O15554	KCNN4_HUMAN	clotrimazole	7.15	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104	ClC1=C(C=CC=C1)C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1	CHEMBL104
Q16850	CP51A_HUMAN	clotrimazole	6.89	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104	ClC1=C(C=CC=C1)C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1	CHEMBL104
P09467	F16P1_HUMAN	adenosine phosphate	6.85	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL752	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O	CHEMBL752
P09871	C1S_HUMAN	nafamostat	6.85	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N	CHEMBL273264
P06870	KLK1_HUMAN	nafamostat	6.19	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N	CHEMBL273264
P0DMS8	AA3R_HUMAN	pirenzepine	7.66	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9967	CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1	CHEMBL9967
P0DMS8	AA3R_HUMAN	yohimbine	7.02	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245	[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2	CHEMBL15245
Q9Y5Y6	ST14_HUMAN	hexamidine	6.03	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25105	NC(=N)C1=CC=C(OCCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1	CHEMBL25105
P50135	HNMT_HUMAN	amodiaquine	7.72	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL682	CCN(CC)CC1=C(O)C=CC(NC2=CC=NC3=CC(Cl)=CC=C23)=C1	CHEMBL682
P14550	AK1A1_HUMAN	tolrestat	6.14	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL436	COC1=CC=C2C(=CC=CC2=C1C(F)(F)F)C(=S)N(C)CC(O)=O	CHEMBL436
O60218	AK1BA_HUMAN	tolrestat	7.3	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL436	COC1=CC=C2C(=CC=CC2=C1C(F)(F)F)C(=S)N(C)CC(O)=O	CHEMBL436
P42330	AK1C3_HUMAN	indomethacin	7.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O	CHEMBL6
P10145	IL8_HUMAN	indomethacin	7.3	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6	COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O	CHEMBL6
P15104	GLNA_HUMAN	prednisolone	7.49	EC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C	CHEMBL131
P04278	SHBG_HUMAN	cortisone acetate	6.43	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111861	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL111861
Q14376	GALE_HUMAN	haloprogin	6.3	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289	ClC1=CC(Cl)=C(OCC#CI)C=C1Cl	CHEMBL1289
P04278	SHBG_HUMAN	hydrocortisone	6.2	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL389621	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL389621
Q15125	EBP_HUMAN	opipramol	7.89	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL370753	OCCN1CCN(CCCN2C3=CC=CC=C3C=CC3=C2C=CC=C3)CC1	CHEMBL370753
P10636	TAU_HUMAN	lansoprazole	8.6	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL480	CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F	CHEMBL480
Q9BY08	EBPL_HUMAN	tamoxifen	8.55	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1	CHEMBL83
P34972	CNR2_HUMAN	nabilone	8.2	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL947	[H]C12CC(=O)CCC1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC	CHEMBL947
P21917	DRD4_HUMAN	clebopride	8.49	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325109	COC1=C(C=C(Cl)C(N)=C1)C(=O)NC1CCN(CC2=CC=CC=C2)CC1	CHEMBL325109
Q16850	CP51A_HUMAN	econazole	7.3	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL808	ClC1=CC=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1	CHEMBL808
P21917	DRD4_HUMAN	tandospirone	8.14	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274047	[H][C@]12CC[C@]([H])(C1)[C@]1([H])C(=O)N(CCCCN3CCN(CC3)C3=NC=CC=N3)C(=O)[C@]21[H]	CHEMBL274047
P08311	CATG_HUMAN	bortezomib	6.2	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O	CHEMBL325041
P17538	CTRB1_HUMAN	bortezomib	6.49	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O	CHEMBL325041
Q00653	NFKB2_HUMAN	bortezomib	8.01	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O	CHEMBL325041
Q04206	TF65_HUMAN	bortezomib	8.01	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041	CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O	CHEMBL325041
P21917	DRD4_HUMAN	nemonapride	9.68	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20734	CNC1=CC(OC)=C(C=C1Cl)C(=O)N[C@@H]1CCN(CC2=CC=CC=C2)[C@@H]1C	CHEMBL20734
Q9HCR9	PDE11_HUMAN	tadalafil	7.48	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL779	[H][C@]12CC3=C(NC4=C3C=CC=C4)[C@]([H])(N1C(=O)CN(C)C2=O)C1=CC=C2OCOC2=C1	CHEMBL779
O14976	GAK_HUMAN	erlotinib	8.51	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2	CHEMBL553
O94804	STK10_HUMAN	erlotinib	7.72	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2	CHEMBL553
Q56UN5	M3K19_HUMAN	erlotinib	7.6	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2	CHEMBL553
Q9H2G2	SLK_HUMAN	erlotinib	7.59	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2	CHEMBL553
Q02880	TOP2B_HUMAN	amsacrine	6.14	EC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL43	COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1	CHEMBL43
P0DMS8	AA3R_HUMAN	ketanserin	8.57	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51	FC1=CC=C(C=C1)C(=O)C1CCN(CCN2C(=O)NC3=CC=CC=C3C2=O)CC1	CHEMBL51
P21917	DRD4_HUMAN	ketanserin	8.46	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51	FC1=CC=C(C=C1)C(=O)C1CCN(CCN2C(=O)NC3=CC=CC=C3C2=O)CC1	CHEMBL51
P21917	DRD4_HUMAN	spiperone	9.7	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930	FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1	CHEMBL267930
P49674	KC1E_HUMAN	sunitinib	7.89	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
O75914	PAK3_HUMAN	sunitinib	7.8	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
O14976	GAK_HUMAN	sunitinib	7.7	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
P48730	KC1D_HUMAN	sunitinib	7.82	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q9H2X6	HIPK2_HUMAN	sunitinib	7.51	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
O43172	PRP4_HUMAN	sunitinib	6.41	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q92918	M4K1_HUMAN	sunitinib	7.8	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
P49760	CLK2_HUMAN	sunitinib	7.7	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q86YV6	MYLK4_HUMAN	sunitinib	7.82	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
P49759	CLK1_HUMAN	sunitinib	7.66	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
O94804	STK10_HUMAN	sunitinib	7.72	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q2M2I8	AAK1_HUMAN	sunitinib	7.96	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
O75582	KS6A5_HUMAN	sunitinib	7.77	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
P15735	PHKG2_HUMAN	sunitinib	8.23	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q15746	MYLK_HUMAN	sunitinib	7.64	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q8N4C8	MINK1_HUMAN	sunitinib	7.54	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q9NSY1	BMP2K_HUMAN	sunitinib	8.26	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q9UEE5	ST17A_HUMAN	sunitinib	9.0	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q9UKE5	TNIK_HUMAN	sunitinib	7.6	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q9HAZ1	CLK4_HUMAN	sunitinib	7.54	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
P51617	IRAK1_HUMAN	sunitinib	7.85	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q13043	STK4_HUMAN	sunitinib	7.72	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q15349	KS6A2_HUMAN	sunitinib	7.77	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q8IYT8	ULK2_HUMAN	sunitinib	7.89	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q16816	PHKG1_HUMAN	sunitinib	8.26	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
O43293	DAPK3_HUMAN	sunitinib	7.66	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q56UN5	M3K19_HUMAN	sunitinib	7.77	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
P30530	UFO_HUMAN	sunitinib	8.05	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
P80370	DLK1_HUMAN	sunitinib	7.0	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q32MK0	MYLK3_HUMAN	sunitinib	7.64	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
O75385	ULK1_HUMAN	sunitinib	7.64	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q9BYT3	STK33_HUMAN	sunitinib	7.77	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
O96017	CHK2_HUMAN	sunitinib	8.15	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
Q12866	MERTK_HUMAN	sunitinib	7.59	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535	CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C	CHEMBL535
P04156	PRIO_HUMAN	mepacrine	6.52	EC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL7568	CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=CC(Cl)=CC=C12	CHEMBL7568
O00519	FAAH1_HUMAN	amperozide	6.34	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1079935	CCNC(=O)N1CCN(CCCC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1	CHEMBL1079935
Q96FL8	S47A1_HUMAN	nifekalant	6.19	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL360861	CN1C(=O)C=C(NCCN(CCO)CCCC2=CC=C(C=C2)[N+]([O-])=O)N(C)C1=O	CHEMBL360861
Q15125	EBP_HUMAN	clomifene	9.0	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2355051	CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1	CHEMBL2355051
Q9BY08	EBPL_HUMAN	trifluoperazine	8.41	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1	CHEMBL422
Q15125	EBP_HUMAN	trifluoperazine	8.1	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422	CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1	CHEMBL422
Q15125	EBP_HUMAN	trifluperidol	6.78	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15023	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC(=CC=C1)C(F)(F)F	CHEMBL15023
P68363	TBA1B_HUMAN	podophyllotoxin	6.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O	CHEMBL61
P68366	TBA4A_HUMAN	podophyllotoxin	6.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O	CHEMBL61
Q13748	TBA3C_HUMAN	podophyllotoxin	6.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O	CHEMBL61
Q6PEY2	TBA3E_HUMAN	podophyllotoxin	6.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O	CHEMBL61
Q71U36	TBA1A_HUMAN	podophyllotoxin	6.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O	CHEMBL61
Q9BQE3	TBA1C_HUMAN	podophyllotoxin	6.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61	[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O	CHEMBL61
Q16850	CP51A_HUMAN	miconazole	6.7	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91	ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1	CHEMBL91
Q9Y5Y4	PD2R2_HUMAN	ramatroban	8.37	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL361812	OC(=O)CCN1C2=C(C[C@@H](CC2)NS(=O)(=O)C2=CC=C(F)C=C2)C2=CC=CC=C12	CHEMBL361812
P02774	VTDB_HUMAN	calcitriol	7.62	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL846	[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O	CHEMBL846
Q16665	HIF1A_HUMAN	topotecan	7.22	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL84	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O	CHEMBL84
P50052	AGTR2_HUMAN	losartan	8.43	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL995	CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1	CHEMBL995
P33527	MRP1_HUMAN	benzbromarone	6.72	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL388590	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2	CHEMBL388590
Q04828	AK1C1_HUMAN	benzbromarone	7.32	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL388590	CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2	CHEMBL388590
P14410	SUIS_HUMAN	acarbose	6.609065055847168	Ki		SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/21669536	[H][C@]1(N[C@@H]2[C@@H](C)O[C@H](O[C@]3([H])[C@@H](CO)O[C@H](O[C@]4([H])[C@@H](CO)OC(O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C=C(CO)[C@@H](O)[C@H](O)[C@H]1O	CHEMBL404271
Q02156	KPCE_HUMAN	ingenol mebutate	8.95860767364502	EC50		SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/15126366	[H][C@@]12C[C@@]([H])(C)[C@]34C=C(C)[C@]([H])(OC(=O)C(\C)=C/C)[C@@]3(O)[C@]([H])(O)C(CO)=C[C@]([H])(C4=O)[C@]1([H])C2(C)C	CHEMBL1863513
Q15139	KPCD1_HUMAN	ingenol mebutate	7.522878646850586	EC50		SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/15126366	[H][C@@]12C[C@@]([H])(C)[C@]34C=C(C)[C@]([H])(OC(=O)C(\C)=C/C)[C@@]3(O)[C@]([H])(O)C(CO)=C[C@]([H])(C4=O)[C@]1([H])C2(C)C	CHEMBL1863513
P21917	DRD4_HUMAN	haloperidol	9.42021656036377	Kd	INVERSE AGONIST	SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/12388666	OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1	CHEMBL54
P51801	CLCKB_HUMAN	niflumic acid	5.0	EC50	ACTIVATOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2439	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1	CHEMBL63323
P36544	ACHA7_HUMAN	ivermectin	5.1	EC50	ALLOSTERIC MODULATOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2373		CHEMBL1200633
Q14973	NTCP_HUMAN	ciclosporin	6.0	IC50	INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1024	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C	CHEMBL160
Q9UL62	TRPC5_HUMAN	progesterone	5.3	IC50	BLOCKER	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2377	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL103
P23416	GLRA2_HUMAN	picrotoxin	5.6	IC50	BLOCKER	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4051		CHEMBL1908342
Q9UHC3	ASIC3_HUMAN	nafamostat	5.6	IC50	BLOCKER	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4262	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N	CHEMBL273264
Q9H2S1	KCNN2_HUMAN	tubocurarine	5.7	IC50	BLOCKER	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2294	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3	CHEMBL339427
P10619	PPGB_HUMAN	boceprevir	6.0	IC50	INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7876	CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C	CHEMBL218394
Q9NPD5	SO1B3_HUMAN	sildenafil	6.1	IC50	INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4743	CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1	CHEMBL192
Q9NPD5	SO1B3_HUMAN	ciclosporin	6.1	IC50	INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1024	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C	CHEMBL160
P48050	KCNJ4_HUMAN	tenidap	6.4	EC50	ACTIVATOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2395	NC(=O)N1C(=O)\C(=C(/O)C2=CC=CS2)C2=C1C=CC(Cl)=C2	CHEMBL1908355
Q92952	KCNN1_HUMAN	dequalinium	6.4	IC50	BLOCKER	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2313	CC1=[N+](CCCCCCCCCC[N+]2=C(C)C=C(N)C3=CC=CC=C23)C2=CC=CC=C2C(N)=C1	CHEMBL333826
Q92753	RORB_HUMAN	tretinoin	9.82	IC50	ANTAGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2644	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O	CHEMBL38
P46663	BKRB1_HUMAN	icatibant	7.0	Ki	ANTAGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=667	[H]N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@]([H])(O)C[C@@]1([H])C(=O)NCC(=O)N[C@@H](CC1=CC=CS1)C(=O)N[C@@H](CO)C(=O)N1CC2=C(C[C@@H]1C(=O)N1[C@@H](C[C@]3([H])CCCC[C@]13[H])C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C2	CHEMBL2028850
P10619	PPGB_HUMAN	telaprevir	7.0	IC50	INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7871	[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1	CHEMBL231813
Q96FL8	S47A1_HUMAN	pyrimethamine	7.1	Ki	INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4800	CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1	CHEMBL36
Q13304	GPR17_HUMAN	adenosine triphosphate	7.43	EC50	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O	CHEMBL14249
P49190	PTH2R_HUMAN	teriparatide	7.8	IC50	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4448	[H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O	CHEMBL525610
Q03181	PPARD_HUMAN	tretinoin	7.8	Kd	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2644	C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O	CHEMBL38
P28566	5HT1E_HUMAN	asenapine	8.0	Ki	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=22	[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1	CHEMBL1201756
Q8NEC5	CTSR1_HUMAN	progesterone	8.11	EC50	ACTIVATOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2377	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL103
Q7RTX7	CTSR4_HUMAN	progesterone	8.11	EC50	ACTIVATOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2377	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL103
Q96P56	CTSR2_HUMAN	progesterone	8.11	EC50	ACTIVATOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2377	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL103
Q86XQ3	CTSR3_HUMAN	progesterone	8.11	EC50	ACTIVATOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2377	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL103
P21917	DRD4_HUMAN	lisuride	8.3	Ki	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=43	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC	CHEMBL157138
P21918	DRD5_HUMAN	lisuride	8.5	Ki	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=43	[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC	CHEMBL157138
P41968	MC3R_HUMAN	afamelanotide	8.9	Ki	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1324	CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O	CHEMBL441738
P33032	MC5R_HUMAN	afamelanotide	9.0	IC50	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1324	CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O	CHEMBL441738
P05129	KPCG_HUMAN	ingenol mebutate	9.79	Ki	ACTIVATOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7443	[H][C@@]12C[C@@]([H])(C)[C@]34C=C(C)[C@]([H])(OC(=O)C(\C)=C/C)[C@@]3(O)[C@]([H])(O)C(CO)=C[C@]([H])(C4=O)[C@]1([H])C2(C)C	CHEMBL1863513
P21917	DRD4_HUMAN	perospirone	10.05	Ki	ANTAGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7556	[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O	CHEMBL1472975
P41968	MC3R_HUMAN	corticotropin	7.06	Ki	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1331	[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O	CHEMBL1201609
O75311	GLRA3_HUMAN	ivermectin	6.400000095367432	EC50	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2373		CHEMBL1200633
P23416	GLRA2_HUMAN	ivermectin	6.400000095367432	EC50	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2373		CHEMBL1200633
P19099	C11B2_HUMAN	ketoconazole	7.173925399780273	IC50	INHIBITOR	SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/18672868	CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1	CHEMBL295698
Q96NT5	PCFT_HUMAN	pemetrexed	7.03	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	CHEMBL225072
Q15125	EBP_HUMAN	triparanol	7.96	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL187709	CCN(CC)CCOC1=CC=C(C=C1)C(O)(CC1=CC=C(Cl)C=C1)C1=CC=C(C)C=C1	CHEMBL187709
P21917	DRD4_HUMAN	sertindole	7.96	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2	CHEMBL12713
P50406	5HT6R_HUMAN	sertindole	8.3	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713	FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2	CHEMBL12713
P32246	CCR1_HUMAN	raltegravir	8.3	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254316	CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1	CHEMBL254316
Q86VL8	S47A2_HUMAN	mitoxantrone	6.28	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O	CHEMBL58
Q96FL8	S47A1_HUMAN	mitoxantrone	6.72	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58	OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O	CHEMBL58
O14976	GAK_HUMAN	gefitinib	8.15	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939	COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1	CHEMBL939
P08183	MDR1_HUMAN	aripiprazole	6.11	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112	ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl	CHEMBL1112
P08183	MDR1_HUMAN	verapamil	6.52	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6966	COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1	CHEMBL6966
P50579	MAP2_HUMAN	fumagillin	9.2	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32838	[H][C@@]1([C@H](OC)[C@@H](CC[C@]11CO1)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)[C@@]1(C)O[C@@H]1CC=C(C)C	CHEMBL32838
Q9NYL2	MLTK_HUMAN	sorafenib	8.2	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1	CHEMBL1336
Q8NE63	HIPK4_HUMAN	sorafenib	8.57	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1	CHEMBL1336
P34913	HYES_HUMAN	sorafenib	7.92	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1	CHEMBL1336
Q16832	DDR2_HUMAN	sorafenib	8.18	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1	CHEMBL1336
Q08345	DDR1_HUMAN	sorafenib	8.82	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1	CHEMBL1336
A5X5Y0	5HT3E_HUMAN	cisapride	6.82	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1	CHEMBL1729
O95264	5HT3B_HUMAN	cisapride	6.82	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1	CHEMBL1729
Q70Z44	5HT3D_HUMAN	cisapride	6.82	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1	CHEMBL1729
Q8WXA8	5HT3C_HUMAN	cisapride	6.82	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729	[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1	CHEMBL1729
P41146	OPRX_HUMAN	buprenorphine	7.11	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142	[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]51CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)C(C)(C)C)=CC=C3O	CHEMBL511142
Q04759	KPCT_HUMAN	ruboxistaurin	8.6	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829	[H][C@@]1(CN(C)C)CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21	CHEMBL91829
Q86V86	PIM3_HUMAN	ruboxistaurin	7.92	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829	[H][C@@]1(CN(C)C)CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21	CHEMBL91829
Q02156	KPCE_HUMAN	ruboxistaurin	7.96	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829	[H][C@@]1(CN(C)C)CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21	CHEMBL91829
P05771	KPCB_HUMAN	ruboxistaurin	8.33	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829	[H][C@@]1(CN(C)C)CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21	CHEMBL91829
Q9Y5Y6	ST14_HUMAN	dibrompropamidine	6.27	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30044	NC(=N)C1=CC(Br)=C(OCCCOC2=C(Br)C=C(C=C2)C(N)=N)C=C1	CHEMBL30044
P80365	DHI2_HUMAN	enoxolone	8.91	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL441687	[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O	CHEMBL441687
P01112	RASH_HUMAN	stallimycin	6.7	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11252	CN1C=C(NC(=O)C2=CC(NC(=O)C3=CC(NC=O)=CN3C)=CN2C)C=C1C(=O)NCCC(N)=N	CHEMBL11252
O43353	RIPK2_HUMAN	dasatinib	7.51	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
Q01538	MYT1_HUMAN	dasatinib	7.2	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P54760	EPHB4_HUMAN	dasatinib	9.47	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
O14976	GAK_HUMAN	dasatinib	8.59	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
Q13163	MP2K5_HUMAN	dasatinib	8.48	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P21709	EPHA1_HUMAN	dasatinib	8.39	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P09769	FGR_HUMAN	dasatinib	9.3	Kd	INHIBITOR	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P42685	FRK_HUMAN	dasatinib	9.51	Kd	INHIBITOR	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P29322	EPHA8_HUMAN	dasatinib	9.62	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P29320	EPHA3_HUMAN	dasatinib	10.03	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P41240	CSK_HUMAN	dasatinib	9.0	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
Q59H18	TNI3K_HUMAN	dasatinib	7.96	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
Q13882	PTK6_HUMAN	dasatinib	8.11	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P51813	BMX_HUMAN	dasatinib	8.85	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P54756	EPHA5_HUMAN	dasatinib	9.62	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P54764	EPHA4_HUMAN	dasatinib	8.92	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P54762	EPHB1_HUMAN	dasatinib	9.35	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P42684	ABL2_HUMAN	dasatinib	9.77	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P51451	BLK_HUMAN	dasatinib	9.68	Kd	INHIBITOR	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
O15197	EPHB6_HUMAN	dasatinib	10.41	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
Q9H0K1	SIK2_HUMAN	dasatinib	8.19	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
Q9H3Y6	SRMS_HUMAN	dasatinib	7.89	Kd	INHIBITOR	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
Q9Y2K2	SIK3_HUMAN	dasatinib	7.55	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
Q16832	DDR2_HUMAN	dasatinib	8.52	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
Q08345	DDR1_HUMAN	dasatinib	9.16	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P29323	EPHB2_HUMAN	dasatinib	9.41	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P42681	TXK_HUMAN	dasatinib	8.68	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P54753	EPHB3_HUMAN	dasatinib	8.16	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P42680	TEC_HUMAN	dasatinib	7.89	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
P57059	SIK1_HUMAN	dasatinib	8.41	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
Q16539	MK14_HUMAN	dasatinib	7.57	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	CHEMBL1421
O76083	PDE9A_HUMAN	vardenafil	6.34	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1339	CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1	CHEMBL1339
Q9HCR9	PDE11_HUMAN	vardenafil	6.89	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1339	CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1	CHEMBL1339
Q86VL8	S47A2_HUMAN	imatinib	6.46	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1	CHEMBL941
Q96FL8	S47A1_HUMAN	imatinib	7.4	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1	CHEMBL941
P42684	ABL2_HUMAN	imatinib	8.22	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1	CHEMBL941
Q16832	DDR2_HUMAN	imatinib	7.82	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1	CHEMBL941
P16083	NQO2_HUMAN	imatinib	6.4	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1	CHEMBL941
Q08345	DDR1_HUMAN	imatinib	9.15	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1	CHEMBL941
Q8N2K0	ABD12_HUMAN	orlistat	7.1	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	CHEMBL175247
Q8NCG7	DGLB_HUMAN	orlistat	7.22	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	CHEMBL175247
Q9Y4D2	DGLA_HUMAN	orlistat	8.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	CHEMBL175247
O95870	ABHGA_HUMAN	orlistat	7.52	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	CHEMBL175247
Q13093	PAFA_HUMAN	orlistat	7.3	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	CHEMBL175247
P41252	SYIC_HUMAN	mupirocin	9.1	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL719	[H][C@@]1(C[C@H]2CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]2O)O[C@@]1([H])[C@@H](C)[C@H](C)O	CHEMBL719
Q86TP1	PRUNE_HUMAN	dipyridamole	6.11	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO	CHEMBL932
Q9HCR9	PDE11_HUMAN	dipyridamole	6.4	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932	OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO	CHEMBL932
O75751	S22A3_HUMAN	chlorhexidine	6.39	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790	ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1	CHEMBL790
O15245	S22A1_HUMAN	chlorhexidine	6.68	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790	ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1	CHEMBL790
O15244	S22A2_HUMAN	chlorhexidine	6.4	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790	ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1	CHEMBL790
Q86VL8	S47A2_HUMAN	chlorhexidine	6.3	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790	ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1	CHEMBL790
Q96FL8	S47A1_HUMAN	chlorhexidine	6.15	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790	ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1	CHEMBL790
P80365	DHI2_HUMAN	acetoxolone	6.7	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL207413	[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](OC(C)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O	CHEMBL207413
P50052	AGTR2_HUMAN	telmisartan	9.48	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1017	CCCC1=NC2=C(C=C(C=C2C)C2=NC3=C(C=CC=C3)N2C)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C(O)=O	CHEMBL1017
Q07817	B2CL1_HUMAN	gossypol	6.32	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483	CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(=C(C)C=C12)C1=C(O)C2=C(C=O)C(O)=C(O)C(C(C)C)=C2C=C1C	CHEMBL51483
Q07820	MCL1_HUMAN	gossypol	6.74	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483	CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(=C(C)C=C12)C1=C(O)C2=C(C=O)C(O)=C(O)C(C(C)C)=C2C=C1C	CHEMBL51483
Q9NYL2	MLTK_HUMAN	nilotinib	7.96	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F	CHEMBL255863
P42684	ABL2_HUMAN	nilotinib	7.59	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F	CHEMBL255863
Q16832	DDR2_HUMAN	nilotinib	8.22	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F	CHEMBL255863
Q08345	DDR1_HUMAN	nilotinib	8.96	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863	CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F	CHEMBL255863
P47898	5HT5A_HUMAN	ergotamine	7.85	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL442	[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O	CHEMBL442
P34913	HYES_HUMAN	fulvestrant	7.59	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H]	CHEMBL1358
P11474	ERR1_HUMAN	fulvestrant	8.7	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H]	CHEMBL1358
P08183	MDR1_HUMAN	reserpine	7.0	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL772	[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2	CHEMBL772
Q401N2	ZACN_HUMAN	tubocurarine	5.2	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL339427	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3	CHEMBL339427
P36544	ACHA7_HUMAN	tubocurarine	5.51	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL339427	[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3	CHEMBL339427
P04745	AMY1_HUMAN	acarbose	6.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404271	[H][C@]1(N[C@@H]2[C@@H](C)O[C@H](O[C@]3([H])[C@@H](CO)O[C@H](O[C@]4([H])[C@@H](CO)OC(O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C=C(CO)[C@@H](O)[C@H](O)[C@H]1O	CHEMBL404271
P25024	CXCR1_HUMAN	itraconazole	7.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64391	CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1	CHEMBL64391
Q96FL8	S47A1_HUMAN	ritonavir	7.1	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL163	CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1	CHEMBL163
Q15393	SF3B3_HUMAN	tacrolimus	7.96	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL269732	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC	CHEMBL269732
Q08209	PP2BA_HUMAN	tacrolimus	7.7	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL269732	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC	CHEMBL269732
Q13451	FKBP5_HUMAN	tacrolimus	7.1	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL269732	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC	CHEMBL269732
P08183	MDR1_HUMAN	vinblastine	7.0	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL159	[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC	CHEMBL159
P80365	DHI2_HUMAN	glycyrrhizic acid	9.4	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL441687	[H][C@@]1(O[C@@H]2[C@@H](O)[C@H](O)[C@H](O[C@]2([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])C(=O)C=C3[C@]5([H])C[C@](C)(CC[C@]5(C)CC[C@@]43C)C(O)=O)C2(C)C)C(O)=O)O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O	CHEMBL441687
Q13822	ENPP2_HUMAN	evans blue	6.08	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1015	CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O	CHEMBL1015
P50052	AGTR2_HUMAN	saralasin	9.82	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL938	CNCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O	CHEMBL938
P06730	IF4E_HUMAN	sirolimus	9.3	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC	CHEMBL413
Q53EL6	PDCD4_HUMAN	sirolimus	7.3	EC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC	CHEMBL413
Q13451	FKBP5_HUMAN	sirolimus	8.52	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC	CHEMBL413
P29371	NK3R_HUMAN	eledoisin	9.66	EC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373569	CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCC(=O)N1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O	CHEMBL373569
Q08209	PP2BA_HUMAN	ciclosporin	8.4	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C	CHEMBL160
Q08752	PPID_HUMAN	ciclosporin	8.15	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C	CHEMBL160
P23284	PPIB_HUMAN	ciclosporin	8.01	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C	CHEMBL160
P68106	FKB1B_HUMAN	ciclosporin	8.22	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C	CHEMBL160
Q02790	FKBP4_HUMAN	ciclosporin	7.8	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C	CHEMBL160
Q96EB6	SIR1_HUMAN	suramin	6.52	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL265502	CC1=CC=C(C=C1NC(=O)C1=CC=CC(NC(=O)NC2=CC=CC(=C2)C(=O)NC2=C(C)C=CC(=C2)C(=O)NC2=CC=C(C3=CC(=CC(=C23)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)=C1)C(=O)NC1=CC=C(C2=CC(=CC(=C12)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O	CHEMBL265502
Q9Y618	NCOR2_HUMAN	vorinostat	8.7	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1	CHEMBL98
O75376	NCOR1_HUMAN	vorinostat	7.92	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98	ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1	CHEMBL98
P34972	CNR2_HUMAN	rimonabant	8.96	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111	CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl)C1=CC=C(Cl)C=C1	CHEMBL111
P43235	CATK_HUMAN	boceprevir	7.4	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394	CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C	CHEMBL218394
O60911	CATL2_HUMAN	boceprevir	7.12	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394	CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C	CHEMBL218394
P23946	CMA1_HUMAN	boceprevir	7.49	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394	CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C	CHEMBL218394
P25774	CATS_HUMAN	boceprevir	6.92	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394	CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C	CHEMBL218394
P43235	CATK_HUMAN	telaprevir	6.2	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813	[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1	CHEMBL231813
P07858	CATB_HUMAN	telaprevir	6.68	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813	[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1	CHEMBL231813
Q9UNI1	CELA1_HUMAN	telaprevir	7.52	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813	[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1	CHEMBL231813
P23946	CMA1_HUMAN	telaprevir	7.59	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813	[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1	CHEMBL231813
P25774	CATS_HUMAN	telaprevir	6.52	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813	[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1	CHEMBL231813
Q12884	SEPR_HUMAN	linagliptin	7.05	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL237500	CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=CC=CC=C3C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1	CHEMBL237500
O43353	RIPK2_HUMAN	vandetanib	8.34	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1	CHEMBL24828
Q08345	DDR1_HUMAN	vandetanib	7.96	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828	COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1	CHEMBL24828
Q9H2G2	SLK_HUMAN	crizotinib	7.74	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl	CHEMBL601719
Q04912	RON_HUMAN	crizotinib	7.6	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl	CHEMBL601719
Q9Y616	IRAK3_HUMAN	crizotinib	7.51	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl	CHEMBL601719
O15197	EPHB6_HUMAN	crizotinib	8.22	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl	CHEMBL601719
P30530	UFO_HUMAN	crizotinib	8.11	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl	CHEMBL601719
Q12866	MERTK_HUMAN	crizotinib	8.44	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719	[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl	CHEMBL601719
P04278	SHBG_HUMAN	hydroxyprogesterone caproate	7.0	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1062	[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL1062
P0DMS8	AA3R_HUMAN	prazosin	9.07	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1	CHEMBL2
P16083	NQO2_HUMAN	prazosin	8.11	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2	COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1	CHEMBL2
O00444	PLK4_HUMAN	axitinib	8.38	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1	CHEMBL1289926
Q9UQB9	AURKC_HUMAN	axitinib	8.89	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1	CHEMBL1289926
Q96GD4	AURKB_HUMAN	axitinib	7.96	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926	CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1	CHEMBL1289926
Q15465	SHH_HUMAN	vismodegib	7.82	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473417	CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1	CHEMBL473417
Q9NY91	SC5A4_HUMAN	dapagliflozin	8.87	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429910	[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC(CC2=CC=C(OCC)C=C2)=C(Cl)C=C1	CHEMBL429910
Q8WWX8	SC5AB_HUMAN	dapagliflozin	6.42	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429910	[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC(CC2=CC=C(OCC)C=C2)=C(Cl)C=C1	CHEMBL429910
Q8TDR2	STK35_HUMAN	bosutinib	8.7	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
P54760	EPHB4_HUMAN	bosutinib	8.04	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
O14976	GAK_HUMAN	bosutinib	8.89	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
Q13163	MP2K5_HUMAN	bosutinib	8.09	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
Q92918	M4K1_HUMAN	bosutinib	7.82	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
P09769	FGR_HUMAN	bosutinib	8.2	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
P42685	FRK_HUMAN	bosutinib	8.85	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
P29322	EPHA8_HUMAN	bosutinib	8.05	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
P29320	EPHA3_HUMAN	bosutinib	8.24	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
O94804	STK10_HUMAN	bosutinib	8.15	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
Q9Y4K4	M4K5_HUMAN	bosutinib	9.3	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
Q8N4C8	MINK1_HUMAN	bosutinib	8.49	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
Q9UKE5	TNIK_HUMAN	bosutinib	7.51	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
Q9H2G2	SLK_HUMAN	bosutinib	8.33	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
P54756	EPHA5_HUMAN	bosutinib	7.57	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
P54764	EPHA4_HUMAN	bosutinib	7.74	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
Q8IVH8	M4K3_HUMAN	bosutinib	8.29	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
Q9Y2U5	M3K2_HUMAN	bosutinib	7.52	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
P42684	ABL2_HUMAN	bosutinib	8.82	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
P51451	BLK_HUMAN	bosutinib	8.48	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
Q9H0K1	SIK2_HUMAN	bosutinib	7.54	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
P42684	ABL2_HUMAN	bosutinib	8.96	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
O95819	M4K4_HUMAN	bosutinib	8.09	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
Q56UN5	M3K19_HUMAN	bosutinib	7.8	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
P29323	EPHB2_HUMAN	bosutinib	8.08	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
P57059	SIK1_HUMAN	bosutinib	7.52	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
Q12851	M4K2_HUMAN	bosutinib	8.51	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441	COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl	CHEMBL288441
Q9UGI6	KCNN3_HUMAN	dequalinium	5.89	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL333826	CC1=[N+](CCCCCCCCCC[N+]2=C(C)C=C(N)C3=CC=CC=C23)C2=CC=CC=C2C(N)=C1	CHEMBL333826
P0DMS8	AA3R_HUMAN	choline theophyllinate	7.85	Ki	ANTAGONIST	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434	C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O	CHEMBL1200434
P41597	CCR2_HUMAN	plerixafor	10.4	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18442	C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1	CHEMBL18442
P0DMS8	AA3R_HUMAN	bufylline	7.85	Ki	ANTAGONIST	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089		CHEMBL2104089
P12104	FABPI_HUMAN	choline fenofibrate	6.0	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL981	CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O	CHEMBL981
Q16678	CP1B1_HUMAN	diosmetin	7.54	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90568	COC1=C(O)C=C(C=C1)C1=CC(=O)C2=C(O)C=C(O)C=C2O1	CHEMBL90568
P05413	FABPH_HUMAN	linolenic acid	8.56	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8739	CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O	CHEMBL8739
P34913	HYES_HUMAN	regorafenib	9.3	IC50	INHIBITOR	CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1946170	CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1	CHEMBL1946170
Q9C098	DCLK3_HUMAN	tofacitinib	8.35	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959	C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N	CHEMBL221959
P51813	BMX_HUMAN	ibrutinib	9.1	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1873475	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C	CHEMBL1873475
P25774	CATS_HUMAN	simeprevir	6.1	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL501849	[H][C@@]12C[C@]1(NC(=O)[C@]1([H])C[C@]([H])(C[C@@]1([H])C(=O)N(C)CCCC\C=C/2)OC1=CC(=NC2=C1C=CC(OC)=C2C)C1=NC(=CS1)C(C)C)C(=O)NS(=O)(=O)C1CC1	CHEMBL501849
Q13163	MP2K5_HUMAN	nintedanib	8.74	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q14680	MELK_HUMAN	nintedanib	8.31	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
O43318	M3K7_HUMAN	nintedanib	8.39	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
P49759	CLK1_HUMAN	nintedanib	8.06	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
P33981	TTK_HUMAN	nintedanib	7.66	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
O75716	STK16_HUMAN	nintedanib	7.74	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
P14616	INSRR_HUMAN	nintedanib	7.68	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q9NSY1	BMP2K_HUMAN	nintedanib	8.66	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q9HAZ1	CLK4_HUMAN	nintedanib	7.74	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q13043	STK4_HUMAN	nintedanib	8.05	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q00536	CDK16_HUMAN	nintedanib	7.68	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q15831	STK11_HUMAN	nintedanib	7.74	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
P32298	GRK4_HUMAN	nintedanib	7.77	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q9Y2U5	M3K2_HUMAN	nintedanib	8.03	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q13523	PRP4B_HUMAN	nintedanib	8.08	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q08345	DDR1_HUMAN	nintedanib	7.92	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q56UN5	M3K19_HUMAN	nintedanib	8.28	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
P30530	UFO_HUMAN	nintedanib	7.92	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
P78356	PI42B_HUMAN	nintedanib	7.77	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q9H093	NUAK2_HUMAN	nintedanib	7.68	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q9UPE1	SRPK3_HUMAN	nintedanib	7.92	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q9BRS2	RIOK1_HUMAN	nintedanib	7.64	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q13976	KGP1_HUMAN	nintedanib	7.85	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q12866	MERTK_HUMAN	nintedanib	8.07	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835	COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2	CHEMBL502835
Q9BPV8	P2Y13_HUMAN	cangrelor	8.3	IC50	ANTAGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1776	CSCCNC1=NC(SCCC(F)(F)F)=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]1O	CHEMBL334966
O75376	NCOR1_HUMAN	romidepsin	9.819999694824219	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL343448	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2	CHEMBL343448
Q15125	EBP_HUMAN	tamoxifen	9.0	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1	CHEMBL83
Q9UBM7	DHCR7_HUMAN	tamoxifen	9.0	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83	CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1	CHEMBL83
P24385	CCND1_HUMAN	palbociclib	8.699999809265137	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189963	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O	CHEMBL189963
P24385	CCND1_HUMAN	palbociclib	8.420000076293945	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189963	CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O	CHEMBL189963
Q15822	ACHA2_HUMAN	nicotine	8.260000228881836	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3	CN1CCC[C@H]1C1=CC=CN=C1	CHEMBL3
Q9Y618	NCOR2_HUMAN	romidepsin	7.739999771118164	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL343448	[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2	CHEMBL343448
Q08828	ADCY1_HUMAN	colforsin daropate	7.389999866485596	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52606	[H][C@@]12[C@H](OC(=O)CCN(C)C)[C@H](OC(C)=O)[C@@]3(C)O[C@](C)(CC(=O)[C@]3(O)[C@@]1(C)[C@@H](O)CCC2(C)C)C=C	CHEMBL52606
P10145	IL8_HUMAN	ibuprofen	7.300000190734863	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL521	CC(C)CC1=CC=C(C=C1)C(C)C(O)=O	CHEMBL521
A5X5Y0	5HT3E_HUMAN	metoclopramide	7.300000190734863	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1	CHEMBL86
O95264	5HT3B_HUMAN	metoclopramide	7.300000190734863	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1	CHEMBL86
Q70Z44	5HT3D_HUMAN	metoclopramide	7.300000190734863	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1	CHEMBL86
Q8WXA8	5HT3C_HUMAN	metoclopramide	7.300000190734863	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86	CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1	CHEMBL86
P07478	TRY2_HUMAN	dabigatran etexilate	7.300000190734863	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1	CHEMBL48361
P35030	TRY3_HUMAN	dabigatran etexilate	7.300000190734863	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1	CHEMBL48361
P43005	EAA3_HUMAN	glutamic acid	7.289999961853027	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232	N[C@@H](CCC(O)=O)C(O)=O	CHEMBL76232
Q15822	ACHA2_HUMAN	nicotine	7.150000095367432	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3	CN1CCC[C@H]1C1=CC=CN=C1	CHEMBL3
Q05901	ACHB3_HUMAN	nicotine	7.070000171661377	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3	CN1CCC[C@H]1C1=CC=CN=C1	CHEMBL3
Q15825	ACHA6_HUMAN	nicotine	7.070000171661377	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3	CN1CCC[C@H]1C1=CC=CN=C1	CHEMBL3
P55789	ALR_HUMAN	pecazine	7.010000228881836	AC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395110	CN1CCCC(CN2C3=CC=CC=C3SC3=CC=CC=C23)C1	CHEMBL395110
P02753	RET4_HUMAN	retinol acetate	6.739999771118164	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL986	CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C	CHEMBL986
P04278	SHBG_HUMAN	estriol succinate	6.630000114440918	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482	[H][C@@]12C[C@@H](OC(=O)CCC(O)=O)[C@H](OC(=O)CCC(O)=O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3CC[C@@]21[H]	CHEMBL193482
P24046	GBRR1_HUMAN	aminobutyric acid	6.570000171661377	EC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL96	NCCCC(O)=O	CHEMBL96
P24557	THAS_HUMAN	tannic acid	6.489999771118164	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247		CHEMBL506247
P55789	ALR_HUMAN	promethazine	6.440000057220459	AC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL643	CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C	CHEMBL643
P55789	ALR_HUMAN	olanzapine	6.429999828338623	AC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2	CHEMBL715
P55789	ALR_HUMAN	pyrithione	6.360000133514404	AC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238	[O-][N+]1=C(S)C=CC=C1	CHEMBL1356238
Q8TCT1	PHOP1_HUMAN	lansoprazole	6.360000133514404	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL480	CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F	CHEMBL480
P40763	STAT3_HUMAN	digitoxin	6.150000095367432	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254219	[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1	CHEMBL254219
P05177	CP1A2_HUMAN	tannic acid	6.039999961853027	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247		CHEMBL506247
P33261	CP2CJ_HUMAN	bicalutamide	6.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL409	CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F	CHEMBL409
Q15822	ACHA2_HUMAN	mecamylamine	5.510000228881836	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267936	[H]C12CCC([H])(C1)C(C)(NC)C2(C)C	CHEMBL267936
P01583	IL1A_HUMAN	rilonacept	11.853872299194336	Kd	INHIBITOR	DRUG LABEL	http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125249lbl.pdf		CHEMBL1201830
P18510	IL1RA_HUMAN	rilonacept	11.214670181274414	Kd	INHIBITOR	DRUG LABEL	http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125249lbl.pdf		CHEMBL1201830
P15328	FOLR1_HUMAN	methotrexate	6.940000057220459	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O	CHEMBL426
P05981	HEPS_HUMAN	dabigatran etexilate	6.079999923706055	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361	CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1	CHEMBL48361
P41440	S19A1_HUMAN	pemetrexed	6.860000133514404	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	CHEMBL225072
P41440	S19A1_HUMAN	raltitrexed	8.199999809265137	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071	CN(CC1=CC2=C(C=C1)N=C(C)NC2=O)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O	CHEMBL225071
O43194	GPR39_HUMAN	zinc chloride	8.4399995803833	EC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200679		CHEMBL1200679
P14410	SUIS_HUMAN	migalastat	6.590000152587891	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O	CHEMBL110458
P68106	FKB1B_HUMAN	sirolimus	9.699999809265137	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413	[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC	CHEMBL413
P68106	FKB1B_HUMAN	tacrolimus	9.399999618530273	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL269732	[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC	CHEMBL269732
O60218	AK1BA_HUMAN	flufenamic acid	6.119999885559082	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23588	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1	CHEMBL23588
Q96NT5	PCFT_HUMAN	methotrexate	6.920000076293945	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O	CHEMBL426
Q96NT5	PCFT_HUMAN	raltitrexed	7.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071	CN(CC1=CC2=C(C=C1)N=C(C)NC2=O)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O	CHEMBL225071
Q99873	ANM1_HUMAN	eosin	6.0	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408917	OC1=C(Br)C2=C(C=C1Br)C1(OC(=O)C3=C1C=CC=C3)C1=CC(Br)=C(O)C(Br)=C1O2	CHEMBL408917
P14207	FOLR2_HUMAN	methotrexate	6.96999979019165	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426	CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O	CHEMBL426
P14207	FOLR2_HUMAN	pemetrexed	7.21999979019165	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072	NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1	CHEMBL225072
P14207	FOLR2_HUMAN	raltitrexed	7.659999847412109	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071	CN(CC1=CC2=C(C=C1)N=C(C)NC2=O)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O	CHEMBL225071
Q9Y5Y6	ST14_HUMAN	nafamostat	10.699999809265137	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264	NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N	CHEMBL273264
O95342	ABCBB_HUMAN	ciclosporin	6.300000190734863	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C	CHEMBL160
O95342	ABCBB_HUMAN	pioglitazone	6.519999980926514	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL595	CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1	CHEMBL595
P21917	DRD4_HUMAN	haloperidol decanoate	8.239999771118164	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986	CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1	CHEMBL1200986
P02753	RET4_HUMAN	vitamin A palmitate	6.74	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL986	CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C	CHEMBL986
P08185	CBG_HUMAN	progesterone	7.38	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103	[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL103
P08185	CBG_HUMAN	hydroxyprogesterone caproate	7.74	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1062	[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL1062
P08185	CBG_HUMAN	hydrocortisone acetate	7.55	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1091	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL1091
P08185	CBG_HUMAN	cortisone acetate	6.89	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111861	[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL111861
P08185	CBG_HUMAN	prednisolone	7.51	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C	CHEMBL131
P08185	CBG_HUMAN	desoxycortone	7.65	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1498	[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL1498
P08185	CBG_HUMAN	aldosterone	6.28	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273453	[H][C@@]12CC[C@H](C(=O)CO)[C@]1(C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C)C=O	CHEMBL273453
P08185	CBG_HUMAN	testosterone	6.72	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL386630	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C	CHEMBL386630
P08185	CBG_HUMAN	nandrolone	6.14	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757	[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]	CHEMBL757
P05067	A4_HUMAN	Florbetapir F-18	8.54	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL578378	CNC1=CC=C(\C=C\C2=CN=C(OCCOCCOCC[18F])C=C2)C=C1	CHEMBL578378
P05067	A4_HUMAN	methylthioninium chloride	6.26	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191083	CN(C)C1=CC2=[S+]C3=CC(=CC=C3N=C2C=C1)N(C)C	CHEMBL191083
P05067	A4_HUMAN	florbetaben F18	8.65	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL566752	CNC1=CC=C(\C=C\C2=CC=C(OCCOCCOCC[18F])C=C2)C=C1	CHEMBL566752
P05362	ICAM1_HUMAN	lifitegrast	8.53	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2048028	[H][C@@](CC1=CC(=CC=C1)S(C)(=O)=O)(NC(=O)C1=C(Cl)C=C2CN(CCC2=C1Cl)C(=O)C1=CC=C2C=COC2=C1)C(O)=O	CHEMBL2048028
P07099	HYEP_HUMAN	triclocarban	6.92	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1076347	ClC1=CC=C(NC(=O)NC2=CC(Cl)=C(Cl)C=C2)C=C1	CHEMBL1076347
P10398	ARAF_HUMAN	dabrafenib	7.59	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2028663	CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1	CHEMBL2028663
P27361	MK03_HUMAN	sorafenib	7.74	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336	CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1	CHEMBL1336
P42892	ECE1_HUMAN	racecadotril	8.1	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10247	CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC1=CC=CC=C1	CHEMBL10247
P78536	ADA17_HUMAN	prednisolone	7.83	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131	[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C	CHEMBL131
Q8TDU6	GPBAR_HUMAN	obeticholic acid	7.0	EC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL566315	[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@H](O)[C@]([H])(CC)[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])CC[C@]12C	CHEMBL566315
Q9Y6L6	SO1B1_HUMAN	ciclosporin	7.29	Ki	INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1024	[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C	CHEMBL160
O94956	SO2B1_HUMAN	erlotinib	6.28	Ki	INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4920	COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2	CHEMBL553
Q6UVM3	KCNT2_HUMAN	flufenamic acid	8.85	EC50	ACTIVATOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2447	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1	CHEMBL23588
Q5JUK3	KCNT1_HUMAN	loxapine	5.36	EC50	ACTIVATOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=205	CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2	CHEMBL831
Q6UVM3	KCNT2_HUMAN	niflumic acid	8.68	EC50	ACTIVATOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2439	OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1	CHEMBL63323
O60840	CAC1F_HUMAN	nimodipine	6.0	IC50	GATING INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2523	COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C	CHEMBL1428
O60840	CAC1F_HUMAN	nitrendipine	6.0	IC50	GATING INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334	CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC	CHEMBL475534
P20813	CP2B6_HUMAN	ticlopidine	6.7	IC50	INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7307	ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1	CHEMBL833
P29973	CNGA1_HUMAN	dequalinium	6.7	IC50	BLOCKER	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2313	CC1=[N+](CCCCCCCCCC[N+]2=C(C)C=C(N)C3=CC=CC=C23)C2=CC=CC=C2C(N)=C1	CHEMBL333826
P49336	CDK8_HUMAN	ponatinib	8.17	Kd	INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5890	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1	CHEMBL1171837
Q9BWU1	CDK19_HUMAN	ponatinib	7.92	Kd	INHIBITOR	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5890	CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1	CHEMBL1171837
P51451	BLK_HUMAN	ibrutinib	10.0	IC50	INHIBITOR	SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/26641137	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C	CHEMBL1873475
P09769	FGR_HUMAN	ibrutinib	8.481486	IC50	INHIBITOR	SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/26641137	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C	CHEMBL1873475
P42680	TEC_HUMAN	ibrutinib	8.154902	IC50	INHIBITOR	SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/26641137	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C	CHEMBL1873475
P42681	TXK_HUMAN	ibrutinib	8.69897	IC50	INHIBITOR	SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/26641137	NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C	CHEMBL1873475
P50052	AGTR2_HUMAN	angiotensin II	10.2	Kd	AGONIST	IUPHAR	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2504	[H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O	CHEMBL408403
P36544	ACHA7_HUMAN	cytisine	5.85	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL497939	[H][C@@]12CNC[C@@]([H])(C1)C1=CC=CC(=O)N1C2	CHEMBL497939
P15104	GLNA_HUMAN	prednisolone tebutate	7.5	EC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C	CHEMBL131
O43193	MTLR_HUMAN	benzamycin	7.36	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL532		CHEMBL532
P08185	CBG_HUMAN	nandrolone decanoate	6.14	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757	[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]	CHEMBL757
P08185	CBG_HUMAN	prednisolone tebutate	7.51	Ki		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131	[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C	CHEMBL131
P0DMS8	AA3R_HUMAN	esatenolol	8.75	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24	CC(C)NC[C@H](O)COC1=CC=C(CC(N)=O)C=C1	CHEMBL24
P04278	SHBG_HUMAN	nandrolone decanoate	6.3	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757	[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]	CHEMBL757
P04278	SHBG_HUMAN	norethindrone acetate	7.97	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1162	[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]	CHEMBL1162
P51817	PRKX_HUMAN	midostaurin	6.02	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1	CHEMBL608533
P27448	MARK3_HUMAN	midostaurin	7.68	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1	CHEMBL608533
Q13043	STK4_HUMAN	midostaurin	7.77	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1	CHEMBL608533
Q9UQM7	KCC2A_HUMAN	midostaurin	7.7	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1	CHEMBL608533
P80192	M3K9_HUMAN	midostaurin	7.82	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1	CHEMBL608533
Q16584	M3K11_HUMAN	midostaurin	7.77	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1	CHEMBL608533
Q16512	PKN1_HUMAN	midostaurin	8.03	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1	CHEMBL608533
Q16513	PKN2_HUMAN	midostaurin	7.82	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1	CHEMBL608533
O95271	TNKS1_HUMAN	niraparib	6.24	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094636	[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1	CHEMBL1094636
Q9UKK3	PARP4_HUMAN	niraparib	6.48	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094636	[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1	CHEMBL1094636
O43172	PRP4_HUMAN	midostaurin	7.26	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1	CHEMBL608533
Q9UHD2	TBK1_HUMAN	midostaurin	8.03	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1	CHEMBL608533
Q9H2K2	TNKS2_HUMAN	midostaurin	6.92	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1	CHEMBL608533
Q56UN5	M3K19_HUMAN	midostaurin	7.82	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533	[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1	CHEMBL608533
Q9NY91	SC5A4_HUMAN	ertugliflozin	9.06	IC50		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1770248	CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1	CHEMBL1770248
O94804	STK10_HUMAN	neratinib	7.89	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C	CHEMBL180022
O00506	STK25_HUMAN	neratinib	7.92	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C	CHEMBL180022
Q9Y4K4	M4K5_HUMAN	neratinib	9.19	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C	CHEMBL180022
Q9P289	STK26_HUMAN	neratinib	8.13	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C	CHEMBL180022
Q56UN5	M3K19_HUMAN	neratinib	7.8	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C	CHEMBL180022
Q8N4C8	MINK1_HUMAN	neratinib	7.54	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C	CHEMBL180022
Q9Y6E0	STK24_HUMAN	neratinib	8.19	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C	CHEMBL180022
Q8IVH8	M4K3_HUMAN	neratinib	8.11	Kd		CHEMBL	https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022	CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C	CHEMBL180022
P0DMS8	AA3R_HUMAN	fostamatinib	7.091514981	IC50	INHIBITOR	SCIENTIFIC LITERATURE	http://www.ncbi.nlm.nih.gov/pubmed/16946104	COC1=CC(NC2=NC(NC3=CC=C4OC(C)(C)C(=O)N(COP(O)(O)=O)C4=N3)=C(F)C=N2)=CC(OC)=C1OC	CHEMBL2103830
Q92800	EZH1_HUMAN	tazemetostat	6.41	IC50	INHIBITOR	DRUG LABEL	https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211723s000lbl.pdf	CCN(C1CCOCC1)C1=CC(=CC(C(=O)NCC2=C(C)C=C(C)NC2=O)=C1C)C1=CC=C(CN2CCOCC2)C=C1	CHEMBL3414621
P19099	C11B2_HUMAN	osilodrostat	9.15	IC50	INHIBITOR	SCIENTIFIC LITERATURE	https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212801s000lbl.pdf	FC1=C(C=CC(=C1)C#N)[C@H]1CCC2=CN=CN12	CHEMBL3099695
